Shares of Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF – Get Free Report) traded down 19.5% during trading on Tuesday . The company traded as low as $9.42 and last traded at $9.42. 1,000 shares changed hands during trading, an increase of 150% from the average session volume of 400 shares. The stock had previously closed at $11.70.
Santhera Pharmaceuticals Trading Down 19.5 %
The stock’s fifty day simple moving average is $11.70 and its 200 day simple moving average is $11.70.
Santhera Pharmaceuticals Company Profile
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes Vamorolone, which is being developed for the treatments of Duchenne muscular dystrophy (DMD).
Featured Stories
- Five stocks we like better than Santhera Pharmaceuticals
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- High Flyers: 3 Natural Gas Stocks for March 2022
- Netflix Is On Track To Hit $1,000 By Christmas
- What Is WallStreetBets and What Stocks Are They Targeting?
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for Santhera Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santhera Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
